Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply

Affiliations

¹ Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
² Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK.
³ Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK. Electronic address: aziz.sheikh@ed.ac.uk.

Comment

Utkarsh Agrawal et al. Lancet. 2023.

. 2023 Apr 29;401(10386):1424.

doi: 10.1016/S0140-6736(23)00444-0.

¹ Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
² Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK.
³ Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK. Electronic address: aziz.sheikh@ed.ac.uk.

No abstract available

Comment on

Moving towards a precision approach for prevention of severe COVID-19.
Branch-Elliman W, Monach PA. Branch-Elliman W, et al. Lancet. 2023 Apr 29;401(10386):1423-1424. doi: 10.1016/S0140-6736(23)00443-9. Lancet. 2023. PMID: 37120280 Free PMC article. No abstract available.

1. Vo AD, La J, Wu JTY, et al. Factors associated with severe COVID-19 among vaccinated adults treated in US Veterans Affairs hospitals. JAMA Netw Open. 2022;5 - PMC - PubMed
1. Agrawal U, Bedston S, McCowan C, et al. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet. 2022;400:1305–1320. - PMC - PubMed
1. Clift AK, Coupland CAC, Keogh RH, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020;371 - PMC - PubMed
1. Tibble H, Mueller T, Proud E, et al. Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland. Lancet. 2023;401:101–102. - PMC - PubMed
1. Mulholland RH, Vasileiou E, Simpson CR, et al. Cohort profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) database. Int J Epidemiol. 2021;50:1064–1074. - PMC - PubMed